Otsuka is voluntarily recalling certain lots of ABILIFY® (aripiprazole) Tablets due to cross-contamination from extremely small amounts of another active pharmaceutical ingredient previously manufactured on the same equipment. Based on sample testing performed, there is no material patient risk associated with the trace level of contamination found. The voluntary recall has been initiated by Otsuka out of an abundance of caution, with the knowledge of the U.S. Food and Drug Administration. This recall is limited to the United States.

Consumers who have a product that is being recalled and who have concerns, should consult with their healthcare provider or pharmacy. Adverse reactions or quality problems experienced with the use of this product should be reported.

Otsuka America Pharmaceutical, Inc. can be reached by phone at 1-833-468-7852 Monday – Friday, 9 a.m. – 5 p.m. Eastern Time or by email: or The FDA's MedWatch Adverse Event Reporting program can be reached either online or by phone. To complete and submit the report Online: or call 1-800-332-1088.

Read more here:

April 2024 01US24EBC0008

We defy limitation, so that others can too.

Otsuka is a healthcare company driven by our purpose and defined by our beliefs.

We have an unwavering belief in doing more.

In transcending expectations and going above and beyond—under any circumstances—for patients, families, providers, and for each other.


We believe in perseverance.

We persist to do what’s right and what matters.


We believe in unconventional thinking.

We live to create and discover a better way.


We believe in humility.

We unite to serve the needs of others before our own.

Next Previous
Blue Stone Small
Blue Stone
Red Stone